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The glucose-6-phosphatase system was investigated in
fetal rat liver microsomal vesicles. Several observations
indicate that the orientation of the catalytic subunit is
different in the fetal liver in comparison with the adult
form: (i) the phosphohydrolase activity was not latent
using glucose-6-phosphate as substrate, and in the case
of other phosphoesters it was less latent; (ii) the intra-
vesicular accumulation of glucose upon glucose-6-phos-
phate hydrolysis was lower; (iii) the size of the intrave-
sicular glucose-6-phosphate pool was independent of
the glucose-6-phosphatase activities; (iv) antibody
against the loop containing the proposed catalytic site
of the enzyme inhibited the phosphohydrolase activity
in fetal but not in adult rat liver microsomes. Glucose-
6-phosphate, phosphate, and glucose uptake could be
detected by both light scattering and/or rapid filtration
method in fetal liver microsomes; however, the intrave-
sicular glucose-6-phosphate and glucose accessible
spaces were proportionally smaller than in adult rat
liver microsomes. These data demonstrate that the com-
ponents of the glucose-6-phosphatase system are al-
ready present, although to a lower extent, in fetal liver,
but they are functionally uncoupled by the extravesicu-
lar orientation of the catalytic subunit.
Hepatic glucose-6-phosphatase system catalyzing the last
step of both gluconeogenesis and glycogenolysis plays a pivotal
role in the maintenance and regulation of blood glucose levels
(1, 2). Accordingly, a huge increase in the activity of the enzyme
can be observed after birth (3, 4). This developmental change
forms the liver to be a gluconeogenic organ and serves the
adaptation of the organism to the feeding-starvation cycles in
the postnatal life. The proper timing of this event is of vital
importance; in several cases very low glucose-6-phosphatase
activities could be detected in the liver of newborns died in
sudden infant death syndrome (5); also, the mean activity of
the enzyme was also lower in preterm children (6).
Several factors can contribute to the fetal-to-neonatal tran-
sition of the glucose-6-phosphatase system. The postnatal hy-
poglycemia and the consequently high glucagon/insulin ratio
may have a primary role (7). Indeed, it has been reported that
dibutyryl cyclic AMP stimulated the transcription of the glu-
cose-6-phosphatase gene in cultured fetal hepatocytes (8). Long
chain fatty acids contributed to the induction by the stabiliza-
tion of the transcript (8). However, the rise in the amount of
mRNA and enzyme protein is lower than the dramatic eleva-
tion of the activity (9), indicating that other, post-transcrip-
tional factors can also affect the protein(s) of the glucose-6-
phosphatase system around the birth.
In adult liver, the catalytic unit of the system is an integral
protein of the endoplasmic reticulum membrane. On the basis
of its proposed structure (10, 11) and the existence of an intra-
vesicular substrate pool (12), it seems very likely that the loop
containing amino acids that contribute to the catalytic site is
orientated toward the lumen of the endoplasmic reticulum, in
accordance with the compartmentational or substrate trans-
port model (2, 13–16). The phenomenon of latency (the enzyme
activity is lower in intact microsomal vesicles than in disrupted
ones) and the strict substrate specificity of the phosphohydro-
lase in intact microsomal vesicles (both determined by the
activity/specificity of the substrate transporter T1) can be ex-
plained by this topological situation. However, several obser-
vations indicate that the compartmentational model is not
sufficient in the case of nongluconeogenic organs and tissues,
including fetal liver. Diminished latency, altered substrate
specificity, different kinetic properties, or unusual lability of
the enzyme could be observed in nongluconeogenic organs ex-
pressing glucose-6-phosphatase (17), esophagus (18, 19), adult
adrenal (20), pancreatic b-cells (21), skeletal muscle (22), as-
trocytes (23), etc. Moreover, even the enzyme from the nuclear
envelope of adult hepatocytes (24) or the microsomal enzyme
prepared from glucocorticoid-treated animals (3, 25) exhibited
moderate latency. A recent study indicated that the intrave-
sicular glucose accumulation upon glucose-6-phosphate hydrol-
ysis, a characteristic feature of adult liver microsomes, was
absent in microsomes from newborn mice (25). These observa-
tions altogether clearly show that the arrangement of the glu-
cose-6-phosphatase system as it can be seen in the endoplasmic
reticulum of the adult liver is a special situation supported by
developmental and local factors. Therefore, experiments were
undertaken to investigate the presence and the characteristics
of the phosphohydrolase and the related transport activities in
fetal rat liver microsomes and their change around the birth.
EXPERIMENTAL PROCEDURES
Preparation of Rat Liver Microsomes—Fetal rat liver microsomes
from 18-day-old fetuses and adult rat liver microsomes from male
Sprague-Dawley rats (180–230 g) were prepared according to Ref. 26.
Microsomal fractions were resuspended in a buffer (buffer A) contain-
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ing: 100 mM KCl, 20 mM NaCl, 1 mM MgCl2, 20 mM Mops,
1 pH 7.2. The
suspensions were rapidly frozen and maintained under liquid nitrogen
until used. Intactness of microsomal vesicles was checked by investi-
gating the osmotically induced changes in microsomal vesicle size upon
the addition of the nonpermeant compound sucrose by the light scat-
tering technique. Microsomes used in this study showed a sustained
shrinking upon sucrose addition (see Fig. 1). Microsomal protein con-
centrations were determined by biuret reaction using bovine serum
albumin as standard.
Uptake Measurements—Liver microsomes (1 mg protein/ml) were
incubated in buffer A containing 0.2–30 mM glucose-6-phosphate plus
[14C]glucose-6-phosphate (8–10 mCi/ml) or 0.2 mM glucose-1-phosphate
plus [14C]glucose-1-phosphate (8–10 mCi/ml) or 1 mM glucose plus
[3H]glucose (9 mCi/ml) or 1 mM sucrose plus [14C]sucrose (1 mCi/ml) at
22 °C. In a series of incubations, the pore-forming antibiotic alamethi-
cin (0.05 mg/ml) was added to distinguish the intravesicular and the
bound radioactivity (27, 28). The alamethicin-releasable portion of ra-
dioactivity was regarded as intravesicular (12). At the indicated time
intervals, samples (0.1 ml) were rapidly filtered through cellulose ace-
tate/nitrate filter membranes (pore size, 0.22 mm) and were washed
with 4 ml of Hepes (20 mM) buffer, pH 7.2, containing 250 mM sucrose
and 0.5 mM 4,49-diisothiocyanostilbene-2,29-disulfonic acid. During the
measurement of glucose-6-phosphate or glucose-1-phosphate uptake
parallel filters were treated after washing with ZnSO4-Ba(OH)2 to
separate glucose from glucose-6-phosphate or glucose-1-phosphate ac-
cording to Ref. 12. The radioactivity associated with microsomes re-
tained by filters was measured by liquid scintillation counting.
Assay of Glucose-6-phosphatase—Glucose-6-phosphatase activity
was measured after 5 min of incubation in buffer A at 22 °C on the basis
of [14C]glucose production from [14C]glucose-6-phosphate according to
Ref. 12. Permeabilized microsomes were treated with 0.05 mg alam-
ethicin/mg protein. Alternatively, the phosphohydrolase activity toward
various phosphoesters was assayed in native and permeabilized micro-
somal vesicles on the basis of phosphate measurement according to Ref.
29. Glucose-6-phosphate content of the incubates was measured enzy-
matically with glucose-6-phosphate dehydrogenase as described in de-
tail earlier (12).
Light Scattering Measurements—Osmotically induced changes in mi-
crosomal vesicle size and shape (30) were monitored at 400 nm at right
angles to the incoming light beam using a fluorimeter (Perkin-Elmer
model 650–10S) equipped with a temperature-controlled cuvette holder
(22 °C) and magnetic stirrer as described elsewhere (31, 32). The mV
output signals were acquired at 0.25-s intervals, using a MacLabTM
hardware (AD Instruments), equipped with a Chart v3.2.5. software.
Antibodies against Various Sections of the Catalytic Subunit of Glu-
cose-6-phosphatase—Antibodies specific to 14 amino acid peptides in
the glucose-6-phosphatase catalytic subunit were raised in Cheviot
sheep. The peptides were synthesized at Severn Biotech Ltd. and re-
ceived as a lyophilized powder. Sequences of the peptides from the
human glucose-6-phosphatase protein against which specific antisera
were raised are shown in Table I. Each peptide had an N-terminal
cysteine residue added to allow for thiol coupling to the carrier protein,
keyhole limpet hemocyanin (Sigma H2133). 20 mg of keyhole limpet
hemocyanin was dissolved in 2 ml of 50 mM sodium phosphate (4:1
dibasic to monobasic). The solution was dialyzed overnight against the
same buffer at 4 °C. The dialyzed keyhole limpet hemocyanin was
treated with 17 ml of 300 mM N-ethylmaleimide (5 mmol). After 30 min
6.2 mg of m-maleimidobenzoyl-N-hydroxy-sulfosuccinimide ester
(Pierce 22312) was added, and after a further 30 min the pH was
adjusted to 6.0 with 1 N HCl. This mixture was dialyzed overnight at
4 °C against 20 mM NaH2PO4/135 mM NaCl, pH 5.6. An equal volume of
20 mM NaH2PO4/150 mM NaCl, pH 8.0, was added to the dialysate. The
pH was adjusted quickly to 6.7. 9 mg of peptide was then added and
dissolved by vigorous vortexing. The pH was determined and brought
back to 6.7 with 1 N NaOH if necessary. The reaction was over in 2 h,
after which the coupled peptide was stored at 220 °C. 185 mg of coupled
peptide was injected subcutaneously into Cheviot sheep with Freund’s
adjuvant on two separate occasions. A third injection of 370 mg was
given for peptide A, and two further injections of 370 mg each were given
for peptides B, C, and D. Serum from the sheep was stored at 270 °C
until use. The four anti-peptide antisera recognize the rat glucose-6-
phosphatase catalytic subunit as shown by Western blot analysis.
For the determination of the effect of the antibodies on glucose-6-
phosphatase activity, native fetal or adult rat microsomes were prein-
cubated in buffer A in the presence of each of the four anti-peptide
antibodies for 50 min at room temperature, under continuous agitation.
The microsomal protein concentration was 0.35 mg/ml, the antibodies
were 100 times diluted in the preincubation mixture. The incubation
was started with the addition 10 mM glucose-6-phosphate. The phos-
phohydrolase activity was detected by measuring glucose or phosphate
production (see above).
Western Blot Analysis—Proteins of the microsomal membranes were
separated by electrophoresis on SDS-polyacrylamide gels (15%) and
electrophoretically transferred to nitrocellulose (22). Western blots
were immunoreacted with a sheep IgG previously shown to be mono-
specific for the glucose-6-phosphatase catalytic subunit (33). The im-
monoreactive band was revealed by a biotin-streptavidin horseradish
peroxidase-linked detection system with 4-chloro-1-naphthol as the
substrate.
Materials—Glucose-6-phosphate (dipotassium salt), mannose-6-
phosphate (dipotassium salt), alamethicin, glucose kit (Trinder meth-
od), D-[1-3H(N)]glucose (0.9 mCi/ml; 15.5 Ci/mmol), and 4,49-diisothio-
cyanostilbene-2,29-disulfonic acid were obtained from Sigma. D-[14C-
(U)]glucose-6-phosphate (0.1 mCi/ml; 300 mCi/mmol) was from Ameri-
can Radiolabeled Chemicals Inc. (St. Louis, MO). [U-14C]sucrose 0.2
mCi/ml; 612 mCi/mmol) and D-[14C(U)]glucose-1-phosphate (0.1 mCi/
ml; 285 mCi/mmol) were obtained from Amersham Pharmacia Biotech.
Cellulose acetate/nitrate filter membranes (pore size, 0.22 mm) were
from Millipore. All other chemicals were of analytical grade.
RESULTS
Transport of Glucose-6-phosphate, Glucose, and Phosphate in
Fetal Rat Liver Microsomal Vesicles—The intactness of the
microsomal vesicles and their permeability toward the sub-
strates and products of the glucose-6-phosphatase system were
investigated by the light scattering technique. Both fetal and
adult microsomal vesicles were practically impermeable to-
ward sucrose, excluding the possibility of the nonspecifically
increased permeability. Glucose-6-phosphate was able to enter
both types of microsomal vesicles, but the rate of entry was
somewhat lower in the fetal microsomes. No major differences
could be observed in the permeation of glucose and phosphate
(Fig. 1). Other hexose phosphates, which are the substrates of
the catalytic subunit, did not permeate the microsomal mem-
brane, their addition caused a prolonged shrinking both in
adult and fetal microsomes with the exception of glucose-1-
phosphate, which was slowly permeable only in fetal vesicles
(Table II).
Transport activities were also assessed using radiolabeled
compounds and a rapid filtration method. Fetal rat liver mi-
crosomes incubated in the presence of various concentrations of
glucose-6-phosphate (plus [14C]glucose-6-phosphate as a
tracer) rapidly accumulated glucose-6-phosphate 1 glucose
reaching a steady-state level in 2 min. More than 90% of the
radioactivity associated to the microsomes was releasable by
the pore-forming alamethicin, indicating the intravesicular ac-
cumulation. In contrast to adult microsomes, fetal vesicles did
not accumulate the isotope over the equilibrium. Separate
measurement of glucose-6-phosphate and glucose revealed that
both compounds were present in the intraluminal space of
vesicles; however, the amount of the intravesicular glucose was
very low compared with that of adult microsomes and hardly
reached the detection limit (Table III). Upon glucose-1-phos-
phate addition (which is a poor substrate of the phosphohydro-
lase, see Table II), the difference in the intravesicular isotope
accumulation was much less expressive between fetal and adult
microsomes, due to the very low glucose production (Table III).1 The abbreviation used is: Mops, 4-morpholinepropanesulfonic acid.
TABLE I
Sequences of the peptides from the human glucose-6-phosphatase
protein
Peptide Sequence Residue
A CSHIHSIYNASLKKY 196–210
B (N-terminal) CMNVLHDFGIQSTHY 5–18
C (C-terminal) CLAQVLGQPHKKSL 345–357
D CLSRIYLAAHFPHQ 168–181
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The steady-state level of intravesicular glucose-6-phosphate
increased linearly by increasing the extravesicular concentra-
tion of glucose-6-phosphate. Consequently, the intravesicular
glucose-6-phosphate accessible space (calculated by dividing
the amount of accumulated glucose-6-phosphate by the ex-
travesicular glucose-6-phosphate concentration) was independ-
ent of the glucose-6-phosphate concentration in the medium
(Fig. 2).
Fetal rat liver microsomal vesicles incubated in the presence
of 1 mM glucose took up the radioactive tracer until a steady-
state level reached over a 5-min period of incubation (Fig. 3).
The uptake was attributable to intravesicular accumulation,
because the majority of radioactivity (.90%) could be released
by permeabilizing the vesicles with the pore-forming alamethi-
cin. The steady-state level of intravesicular glucose was stable
for at least 2 h. In the steady-state phase of glucose uptake, the
apparent intravesicular glucose space, which was calculated by
dividing the intravesicular glucose content (nmol/mg protein)
with the extravesicular glucose concentration (nmol/ml), was
0.23 6 0.04 (ml/mg protein) at 1 mM glucose concentration. This
apparent space was about 50% of that observed in adult rat
liver microsomes by using the same method (Table III).
Because the intravesicular glucose-6-phosphate, glucose-1-
phosphate, and glucose accessible spaces of fetal liver micro-
somes were lower than the corresponding maximal values ob-
tained in adult microsomes, we have estimated the total
intravesicular space measuring the sucrose accessible space of
microsomes. Sucrose, a poorly permeant compound, reached a
steady-state level of uptake at 2 h of incubation. The value of
the intravesicular sucrose space was also 2-fold higher in adult
rat liver microsomes (Table III).
Glucose-6-phosphatase Activity in Fetal Rat Liver Microso-
mal Vesicles—The total phosphohydrolase activity in fetal mi-
crosomes was less than 5% of the adult value (Tables II and IV).
According to Western blot analysis, the amount of the enzyme
protein was less than in adult microsomes, yet it was clearly
detectable (Fig. 4). The latency of the enzyme was almost
absent; permeabilization of the vesicles elevated the activity
slightly, whereas in adult microsomes more than 50% of the
activity was latent (Table II). The difference in glucose-6-phos-
phatase activities obtained by the addition of various concen-
trations of glucose-6-phosphate did not affect the extent of the
intravesicular glucose-6-phosphate accessible space (Fig. 2.).
Hydrolysis of other phosphoesters (10 mM) by fetal micro-
somes showed diminished latency compared with adult micro-
somes (Table II). Very moderate latency was observed in the
case of glucose-1-phosphate and fructose-6-phosphate, whereas
the phosphohydrolase activity toward mannose-6-phosphate,
deoxyglucose-6-phosphate, and glucosamine-6-phosphate re-
mained latent in two-thirds. The eventual conversion of the
hexose phosphates to glucose-6-phosphate during the incuba-
tion (which has been reported in brain microsomes, for exam-
ple; Ref. 23) was checked by measuring the glucose-6-phos-
phate content at 0 and 30 min of incubation. We have found low
glucose-6-phosphate contents, presumably due to the impurity
of chemicals. The highest value, in the case of fructose-6-phos-
phate, was 0.04 mM at the start of incubation (0.4% of the added
fructose-6-phosphate) and 0.07 mM at 30 min. Other incubates
contained less than 0.01 mM glucose-6-phosphate, a value that
did not increase during the incubation (data not shown).
Inhibition of the Phosphohydrolase Activity by Antibodies
Against Different Sections of Glucose-6-phosphatase—Native
fetal and adult microsomal vesicles were preincubated in the
presence of antibodies raised against different sections of glu-
cose-6-phosphatase: the N- and C-terminal parts, an external
loop, and an internal loop containing the His residue that
belongs to the active site of the enzyme. After 50 min of prein-
cubation 10 mM glucose-6-phosphate was added, and the glu-
cose-6-phosphatase activities were measured. In adult micro-
somes neither of the antibodies affected the phosphohydrolase
activity. On the contrary, in fetal microsomes antibodies A and
D, raised against two loops supposed to be orientated toward
the cytosol and the lumen in adult liver, strongly inhibited the
enzyme (Table IV).
DISCUSSION
The results of the present study demonstrate that the com-
ponents of the hepatic glucose-6-phosphatase system are al-
ready present in the fetal liver, although at a lower extent. In
FIG. 1. Influx of glucose-6-phosphate, glucose, and phosphate
into liver microsomal vesicles evaluated by a light scattering
technique. Light scattering measurements were performed as de-
scribed under “Experimental Procedures.” Light scattering increase
was assumed to reflect shrinkage of microsomal vesicles (30, 31). Os-
motically induced changes in microsomal vesicle size and shape were
initiated by adding 0.1 ml (black arrowhead) of concentrate solutions of
sucrose (Sucr), glucose-6-phosphate (G6P), potassium phosphate (Pi,
pH 7.0), or glucose (Glc) to 1.5 ml of the microsomal suspensions (in a
hypoosmotic buffer at pH 7.0; 70 or 35 mg protein/ml, for adult and fetal
microsomes, respectively), giving the final concentration 75 mM (su-
crose), 50 mM (glucose), or 30 mM (glucose-6-phosphate and phosphate).
Alamethicin (10 mg/ml; open arrowheads) was then added to fully per-
meabilize microsomal vesicles (28). The addition of the poorly permea-
ble sucrose resulted in a sustained shrinkage of vesicles indicating
intactness of microsomal membrane. The recovery of initial signal
(swelling phase) after glucose-6-phosphate, glucose, or potassium phos-
phate addition was assumed to reflect their entry into vesicles. The
shrinking phase (dotted lines) has been graphically reconstructed by
taking into account the loss of the light scattering intensity due to
dilution of microsomal suspensions after solute additions. Traces are
representative of two to five separate measurements.
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accordance with earlier studies the catalytic subunit of the
enzyme can be demonstrated by Western blotting, although the
microsomal phosphohydrolase activity in fetal liver is less than
the 5% of the adult one. The transporters belonging to the
system (T1, T2, and T3) are also present, because microsomal
transport of glucose-6-phosphate, glucose, and phosphate can
also be detected by uptake measurements. However, the in-
traluminal glucose-6-phosphate and glucose spaces are 40–
50% of the values observed in adult rat liver microsomal vesi-
cles. These alterations might suggest that the corresponding
transporters are present in a lower percentage of fetal micro-
somal vesicles. More probably, they can reflect the differences
in the protein content and/or vesicle size between fetal and
adult microsomal preparations. This latter possibility is sup-
ported by the facts that (i) the light scattering behavior of fetal
and adult microsomes is similar in the presence of glucose or
glucose-6-phosphate and (ii) the intravesicular sucrose space,
which is nearly as extensive as the intravesicular water space
(32), is proportionally lower in fetal microsomes.
TABLE II
Latency of the phosphohydrolase activity towards various sugar phosphoesters in fetal and adult rat liver microsomes
Microsomal vesicles (1 mg protein/ml) were incubated in buffer A in the presence of various phosphoesters (10 mM) for 30 min (fetal) or 5 min
(adult) at room temperature. Phosphate production was measured. Permeabilized microsomes were treated with 50 mg/ml alamethicin. Data are
the means 6 S.D. of three to six experiments. The influx rates of the phosphoesters (25 mM) into microsomal vesicles expressed as half-time of the
light scattering signal are also shown (n 5 2–5).
Hexose phosphates
Fetal rat liver microsomes Adult rat liver microsomes
Phosphohydrolase activity
Latency T1/2 of influx
Phosphohydrolase activity
Latency T1/2 of influx
Native Permeabilized Native Permeabilized
nmol/min/mg protein % s nmol/min/mg protein % s
Glucose-6-phosphate 13.2 6 1.6 13.2 6 1.6 10 28 6 5 149 6 14 303 6 18 51 17 6 3
Glucose-1-phosphate 2.9 6 0.1 3.1 6 0.1 5 57 6 13 1.9 6 0.6 45 6 4 96 .300
Mannose-6-phosphate 4.4 6 0.2 14.2 6 1.8 69 .300 13.4 6 0.4 279 6 15 95 .300
Deoxyglucose-6-phosphate 4.8 6 0.1 14.2 6 0.4 66 .300 25.7 6 1.9 266 6 16 90 .300
Fructose-6-phosphate 8.6 6 0.3 10.0 6 2.3 15 .300 46.8 6 6.9 151 6 23 69 .300
Glucosamine-6-phosphate 5.8 6 1.1 18.0 6 2.8 67 .300 19.5 6 1.0 327 6 20 94 .300
TABLE III
Uptake and hydrolysis of glucose-6-phosphate in fetal rat liver
microsomal vesicles
Liver microsomes (1 mg/ml) were incubated in buffer A containing 0.2
glucose-6-phosphate (in some experiments glucose-1-phosphate) plus
[14C]glucose-6-phosphate ([14C]glucose-1-phosphate) (8–10 mCi/ml). In
a series of incubations the pore-forming antibiotic alamethicin (0.05
mg/ml) was added to distinguish the intravesicular and the bound
radioactivity. The alamethicin releasable (i.e. intravesicular) portion of
radioactivity is shown. At the steady-state level of uptake (5–10 min),
samples (0.1 ml) were rapidly filtered and washed; the intravesicularly
accumulated glucose deriving from glucose-6-phosphate (glucose-1-
phosphate) hydrolysis during the measurement of glucose-6-phosphate
uptake was measured parallelly as described under “Experimental
Procedures.” For the measurement of intravesicular glucose and su-
crose spaces, 1 mM glucose plus [3H]glucose (9 mCi/ml) or 1 mM sucrose
plus [14C]sucrose (1 mCi/ml) were incubated with microsomal vesicles
for 2 h at 22 °C. At the end of the incubation the intravesicular radio-
activity was assessed as described for glucose-6-phosphate. Apparent
intravesicular isotope spaces were calculated according to the formula:
apparent intravesicular space (ml/mg protein) 5 intravesicular accumu-
lation (nmol/mg protein)/concentration of the added compound (nmol/
ml). The same measurements were also executed on adult rat liver
microsomal vesicles. The abbreviations used in the table are: G6P,
glucose-6-phosphate; G1P, glucose-1-phosphate; NM, not measurable.
Intravesicular accumulation upon addition of
0.2 mM glucose-6-phosphate
Fetal rat liver
microsomes
Adult rat liver
microsomes
nmol/mg protein
G6P 1 glucose 0.16 6 0.03 (5) 1.73 6 0.13 (4)a
G6P 0.11 6 0.03 (5) 0.33 6 0.09 (4)a
Glucose 0.046 6 0.035 (5) 1.40 6 0.10 (4)a
Intravesicular accumulation upon addition of
0.2 mM glucose-1-phosphate
Fetal rat liver
microsomes
Adult rat liver
microsomes
nmol/mg protein
G1P 1 glucose 0.13 6 0.01 (3) 0.30 6 0.07 (3)
Glucose NM NM
Calculated intravesicular isotope spaces
Fetal rat liver
microsomes
Adult rat liver
microsomes
ml/mg protein
G6P 1 glucose 0.80 6 0.15 (5) 8.65 6 0.65 (4)a
G6P 0.57 6 0.15 (5) 1.65 6 0.45 (4)a
G1P 0.65 6 0.05 (3) 1.50 6 0.35 (3)
Sucrose 1.23 6 0.13 (3) 2.83 6 0.24 (3)
Glucose 0.24 6 0.04 (4) 0.43 6 0.09 (6)b
a Data taken from Ref. 12.
b Data taken from Ref. 40.
FIG. 2. The intravesicular glucose-6-phosphate space in fetal
rat liver microsomal vesicles. Microsomes were incubated in the
presence of 0.2–30 mM glucose-6-phosphate plus [14C]glucose-6-phos-
phate as tracer for 5 min. The glucose-6-phosphatase activities and the
intravesicular glucose-6-phosphate contents were measured (for details
see the legend to Table III). The glucose-6-phosphate-accessible intra-
vesicular space of microsomes was calculated using the following for-
mula: intravesicular glucose-6-phosphate space (ml/mg protein) 5
intravesicular glucose-6-phosphate content (nmol/mg protein)/
extravesicular glucose-6-phosphate concentration (nmol/ml). Glucose-6-
phosphate space is shown as a function of both extravesicular glucose-
6-phosphate concentration (open symbols) and microsomal glucose-6-
phosphatase activity (filled symbols). The values are the means 6 S.D.
of three to six experiments.
Glucose-6-phosphatase in Fetal Rat Liver120
 by guest, on Novem
ber 15, 2012
w
w
w
.jbc.org
D
ow
nloaded from
 
Beyond the quantitative differences, fetal liver microsomes
also differ qualitatively. Permeabilization of the microsomal
vesicles by alamethicin slightly increases the phosphohydro-
lase activity, i.e. the latency of the enzyme is minimal. Using
other substrates than glucose-6-phosphate, we have also ob-
served reduced latency that is accompanied with a reduced
substrate specificity. The intravesicular accumulation of glu-
cose due to glucose-6-phosphate hydrolysis is hardly measura-
ble, in accordance with the observation of Annabi and van de
Werve (25). The intravesicular glucose-6-phosphate space,
which is in inverse ratio to the extravesicular glucose-6-phos-
phate concentration and the consequent glucose-6-phosphatase
activity in adult rat liver microsomes (12), is stable independ-
ently of extravesicular glucose-6-phosphate concentrations. It
suggests that in fetal rat liver microsomes glucose-6-phospha-
tase does not utilize an intravesicular substrate pool.
The differences between fetal and adult glucose-6-phospha-
tase system can be explained in several ways. The nonspecific
increase of membrane permeability in fetal microsomal vesicles
is out of the question on the basis of normal sucrose response in
light scattering and the presence of intravesicular pools. The
altered (diminished) specificity of glucose-6-phosphate trans-
porter and/or the presence of other transporter(s) responsible
for the permeation of other phosphoesters may also be sup-
posed. However, other hexose-6-phosphates are not permeable
on the basis of light scattering experiments. Furthermore, the
altered balance of transport and hydrolysis, i.e. the very low
phosphohydrolase activity together with the quasi normal
transport processes, may cease the rate-limiting property of
glucose-6-phosphate transport, which is characteristic of adult
microsomes. This explanation can account for the diminished
latency of the system in the presence of glucose-6-phosphate
and the low intravesicular glucose accumulation upon glucose-
6-phosphate hydrolysis. In itself it is not enough to explain the
decreased latency of phosphohydrolase toward other phos-
phoesters. On the basis of the results we suppose that the
changed orientation of the proposed active site of glucose-6-
phosphatase can be responsible for the altered features of glu-
cose-6-phosphatase system in fetal rat liver microsomes. This
feature of the enzyme is not without precedents: multiple top-
ological orientations linked with different functions has been
reported in the case of other membrane proteins (34–36). The
premise of the presence of a phosphohydrolase orientated with
its catalytic site toward the cytosolic surface of the endoplasmic
reticulum membrane is compatible with the reduced latency,
the relative substrate specificity in native microsomes, the
phosphohydrolase-independent intravesicular glucose-6-phos-
phate pool, and the small intravesicular glucose accumulation.
The inhibitory effect of an antibody against the loop containing
the proposed active site of the enzyme, which was present only
in the fetal microsomal vesicles, strongly supports this hypoth-
esis. Because glucose-6-phosphate transport is present in fetal
microsomes, it means that the transport and hydrolysis are at
least partially uncoupled. Due to the altered orientation, the
enzyme can act as a rather nonspecific phosphohydrolase or,
alternatively, can catalyze the inverse reaction (37), i.e. it may
replace the glucokinase activity missing in the neonatal period
(38).
It has been observed previously that the latency of the glu-
cose-6-phosphatase system (and other microsomal enzymes
with different time course; Ref. 39) increases rapidly around
the birth. It may be caused by the change of orientation of the
enzyme or by the replacement of the fetal isozyme with an
adult form. In the first case it can be supposed that the folding
of the protein converts it into a more active, more specific,
intralumenally orientated form. The activation of preformed
proteins by folding together with the increased transcription of
glucose-6-phosphatase gene may serve the rapid accommoda-
tion to the new gluconeogenic/glycogenolytic role of the liver
after the birth.
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